Pharmacy Medical News about Erectile Dysfunction

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The ENDOTRIAL Study: A Spontaneous, Open-Label, Randomized, Multicenter, Crossover Study on the Efficacy of Sildenafil, Tadalafil, and Vardenafil in the Treatment of Erectile Dysfunction
The Journal of Sexual Medicine, 07/02/09

Jannini EA et al. - An overall equivalence was demonstrated in the subjective perception of treatment benefits for all the PDE5i tested. However, sildenafil, in a dose-dependent manner, was the unique PDE5i able to ameliorate some of the penile flow parameters within the 8-week treatment period. These findings should be interpreted conservatively because of the observational nature of the study.

<< Previous
A phase I/II trial of fixed-dose docetaxel plus irinotecan and...

Next >>
Role of multidrug transporters in neurotherapeutics

Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09 Relevance Score: 70%

Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study
The Journal of Sexual Medicine, 10/28/09 Relevance Score: 69%

Evaluation of Microalbuminuria in Patients with Erectile Dysfunction
The Journal of Sexual Medicine, 10/07/09 Relevance Score: 69%

New Drug Udenafil for Erectile Dysfunction in US Trials
Internet Source, 11/10/09 Relevance Score: 68%

The Association of Serum Prolidase Activity and Erectile Dysfunction
Journal of Andrology, 10/23/09 Relevance Score: 68%